Deep Learning-Based Differential Diagnosis of Follicular Thyroid Tumors Using Histopathological Images.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published Date:

Abstract

Deep learning systems (DLSs) have been developed for the histopathological assessment of various types of tumors, but none are suitable for differential diagnosis between follicular thyroid carcinoma (FTC) and follicular adenoma (FA). Furthermore, whether DLSs can identify the malignant characteristics of thyroid tumors based only on random views of tumor tissue histology has not been evaluated. In this study, we developed DLSs able to differentiate between FTC and FA based on 3 types of convolutional neural network architecture: EfficientNet, VGG16, and ResNet50. The performance of all 3 DLSs was excellent (area under the receiver operating characteristic curve = 0.91 ± 0.04; F1 score = 0.82 ± 0.06). Visual explanations using gradient-weighted class activation mapping suggested that the diagnosis of both FTC and FA was largely dependent on nuclear features. The DLSs were then trained with FTC images and linked information (presence or absence of recurrence within 10 years, vascular invasion, and wide capsular invasion). The ability of the DLSs to diagnose these characteristics was then determined. The results showed that, based on the random views of histology, the DLSs could predict the risk of FTC recurrence, vascular invasion, and wide capsular invasion with a certain level of accuracy (area under the receiver operating characteristic curve = 0.67 ± 0.13, 0.62 ± 0.11, and 0.65 ± 0.09, respectively). Further improvement of our DLSs could lead to the establishment of automated differential diagnosis systems requiring only biopsy specimens.

Authors

  • Satoshi Nojima
    Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tokimu Kadoi
    Graduate School of Medical Life Science, Yokohama City University, Kanagawa, Japan.
  • Ayana Suzuki
    Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.
  • Chiharu Kato
    International College of Arts and Science, Yokohama City University, Kanagawa, Japan.
  • Shoichi Ishida
    Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa 230-0045, Japan.
  • Kansuke Kido
    Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kazutoshi Fujita
    Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yasushi Okuno
    Graduate School of Medicine, Kyoto University, Shogoin-kawaharacho, city/>Sakyo-ku Kyoto, 606-8507, Japan.
  • Mitsuyoshi Hirokawa
    Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.
  • Kei Terayama
    Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa 230-0045, Japan.
  • Eiichi Morii
    Department of Pathology, Osaka University Graduate School of Medicine, Suita-city, Osaka.